7 assets in Autosomal Dominant Parkinson Disease 1

Therapeutic assets addressing Autosomal Dominant Parkinson Disease 1, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Autosomal Dominant Parkinson Disease 1	Shandong New Time Pharmaceutical Co., LTD	P2	CCC (53)
f520 Autosomal Dominant Parkinson Disease 1	Shandong New Time Pharmaceutical Co., LTD	P2	CCC (53)
Lenvatinib Autosomal Dominant Parkinson Disease 1	The First Affiliated Hospital with Nanjing Medical University	P2	CCC (53)
Ruxoprubart Autosomal Dominant Parkinson Disease 1	Shanghai Pulmonary Hospital, Shanghai, China	P2	CCC (53)
Tuvonralimab Autosomal Dominant Parkinson Disease 1	Anhui Provincial Hospital	P2	CCC (53)
pd-1 knockout engineered t cells Autosomal Dominant Parkinson Disease 1	Ruijin Hospital	P1	CC (41)
pd1-til Autosomal Dominant Parkinson Disease 1	Ruijin Hospital	P1	CC (41)